 |
|
Clinicopathologic Factors Affecting Recurrence after Curative Surgery for Stage I Colorectal Cancer
Min Ae Keum, Seok-Byung Lim, Sun A Kim, Yong Sik Yoon, Chan Wook Kim, Chang Sik Yu, Jin Cheon Kim
J Korean Soc Coloproctol. 2012;28(1):49-55. Published online 2012 Feb 29 DOI: https://doi.org/10.3393/jksc.2012.28.1.49
|
|
Citations to this article as recorded by
 Tumor-Informed Circulating Tumor DNA for Minimal Residual Disease Detection in the Management of Colorectal Cancer
Oluwadunni E. Emiloju, Michael Storandt, Tyler Zemla, Nguyen Tran, Krishan Jethwa, Amit Mahipal, Jessica Mitchell, Cornelius Thiels, Kellie Mathis, Robert McWilliams, Joleen Hubbard, Frank Sinicrope, Qian Shi, Zhaohui Jin
JCO Precision Oncology.2024;[Epub] CrossRef Survival outcomes of stage I colorectal cancer: development and validation of the ACEPLY model using two prospective cohorts
Qingbin Wu, Pengju Chen, Chi Shu, Lin Chen, Zechuan Jin, Jun Huang, Xin Wang, Xue Li, Mingtian Wei, Tinghan Yang, Xiangbing Deng, Aiwen Wu, Yazhou He, Ziqiang Wang
BMC Medicine.2023;[Epub] CrossRef Risk factors of recurrence in TNM stage I colorectal cancer
Jin-Hee Paik, Chun-Geun Ryu, Dae-Yong Hwang
Annals of Surgical Treatment and Research.2023; 104(5): 281. CrossRef Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern?
Ryosuke Okamura, Yoshiro Itatani, Yusuke Fujita, Nobuaki Hoshino, Shintaro Okumura, Kazuhiro Nishiyama, Koya Hida, Kazutaka Obama
World Journal of Surgical Oncology.2023;[Epub] CrossRef Immediate Adjuvant Chemotherapy in Non-Metastatic Colon Cancer: Phase I Trial Evaluating a Novel Treatment Protocol
Mehraneh D. Jafari, Joseph C. Carmichael, Farshid Dayyani, Chelsea McKinney, Lari Wenzel, Jason A. Zell, Alessio Pigazzi
Clinical Colorectal Cancer.2022; 21(2): 114. CrossRef The clinic factors in evaluating long-term outcomes of patients with stage I colorectal cancer
Zechuan Jin, Qingbin Wu, Xiangbing Deng, Ziqiang Wang
Asian Journal of Surgery.2022; 45(11): 2231. CrossRef Identification of high-risk stage I colon and rectal cancer patients: a retrospective analysis of a large Japanese cohort
Yudai Fukui, Koya Hida, Nobuaki Hoshino, Daisuke Nishizaki, Ryosuke Okamura, Shinichi Yamauchi, Kenichi Sugihara, Yoshiharu Sakai, I. Takemasa, K. Hakamada, H. Kameyama, Y. Takii, H. Ueno, H. Ozawa, S. Ishihara, K. Takahashi, Y. Kanemitsu, M. Itabashi, T.
International Journal of Colorectal Disease.2022; 37(6): 1403. CrossRef Predicting liver metastases growth patterns: Current status and future possibilities
Rui Caetano Oliveira, Henrique Alexandrino, Maria Augusta Cipriano, Filipe Caseiro Alves, José Guilherme Tralhão
Seminars in Cancer Biology.2021; 71: 42. CrossRef Improved outcomes and staging in non-small-cell lung cancer guided by a molecular assay
Alexander R Gupta, Gavitt A Woodard, David M Jablons, Michael J Mann, Johannes R Kratz
Future Oncology.2021; 17(34): 4785. CrossRef Tumor Size >5 cm and Harvested LNs <12 Are the Risk Factors for Recurrence in Stage I Colon and Rectal Cancer after Radical Resection
Hye-Sol Jung, Seung-Bum Ryoo, Han-Ki Lim, Min Jung Kim, Sang Hui Moon, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park
Cancers.2021; 13(21): 5294. CrossRef High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer
Andreas H Marx, Claudius Mickler, Guido Sauter, Ronald Simon, Luigi M Terracciano, Jakob R Izbicki, Till S Clauditz
International Journal of Colorectal Disease.2020; 35(2): 259. CrossRef Factors influencing recurrence of stage I–III rectal cancer in regional Australia
Lucy Haggstrom, Sharlyn Kang, Robert Winn, Soni Putnis, Elias Nasser, James Chen, Morteza Aghmesheh, Daniel Brungs
ANZ Journal of Surgery.2020; 90(12): 2490. CrossRef Pathological risk factors and predictive endoscopic factors for lymph node metastasis of T1 colorectal cancer: a single-center study of 846 lesions
Chihiro Yasue, Akiko Chino, Manabu Takamatsu, Ken Namikawa, Daisuke Ide, Shoichi Saito, Masahiro Igarashi, Junko Fujisaki
Journal of Gastroenterology.2019; 54(8): 708. CrossRef Influence of gross tumor morphology on clinicopathological profile of colorectal cancers
Mudassir Ahmad Khan, Nisar A. Chowdri, Showkat Ali Bhat, Fazl Q. Parray, Rauf A. Wani, Asif Mehraj
Current Medicine Research and Practice.2019; 9(5): 172. CrossRef Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection
Chan Kim, Woo Ram Kim, Ki-Yeol Kim, Hong Jae Chon, Seung Hoon Beom, Hyojoong Kim, Minkyu Jung, Sang Joon Shin, Nam Kyu Kim, Joong Bae Ahn
Clinical Colorectal Cancer.2018; 17(3): e513. CrossRef Emergency resection surgery for colorectal cancer: Patterns of recurrent disease and survival
Joe Littlechild, Muneer Junejo, Anne-Marie Simons, Finlay Curran, Darren Subar
World Journal of Gastrointestinal Pathophysiology.2018; 9(1): 8. CrossRef Identification of Recurrence—Predictive Indicators in Stage I Colorectal Cancer
Jun Ho Lee, Jong Lyul Lee, In Ja Park, Seok‐Byung Lim, Chang Sik Yu, Jin Cheon Kim
World Journal of Surgery.2017; 41(4): 1126. CrossRef Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016
Alessandro Lugli, Richard Kirsch, Yoichi Ajioka, Fred Bosman, Gieri Cathomas, Heather Dawson, Hala El Zimaity, Jean-François Fléjou, Tine Plato Hansen, Arndt Hartmann, Sanjay Kakar, Cord Langner, Iris Nagtegaal, Giacomo Puppa, Robert Riddell, Ari Ristimäk
Modern Pathology.2017; 30(9): 1299. CrossRef Tumor budding in colorectal cancer—ready for diagnostic practice?
Viktor H. Koelzer, Inti Zlobec, Alessandro Lugli
Human Pathology.2016; 47(1): 4. CrossRef Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis
Sun A Kim, Kentaro Inamura, Mai Yamauchi, Reiko Nishihara, Kosuke Mima, Yasutaka Sukawa, Tingting Li, Mika Yasunari, Teppei Morikawa, Kathryn C Fitzgerald, Charles S Fuchs, Kana Wu, Andrew T Chan, Xuehong Zhang, Shuji Ogino, Zhi Rong Qian
British Journal of Cancer.2016; 114(2): 199. CrossRef Recurrence in patients with stage I colorectal cancer
Patrick Ely Teloken, David Ransom, Ian Faragher, Ian Jones, Peter Gibbs, Cameron Platell
ANZ Journal of Surgery.2016; 86(1-2): 49. CrossRef Preoperative Carcinoembryonic Antigen and Prognosis of Colorectal Cancer. An Independent Prognostic Factor Still Reliable
Giovanni Li Destri, Antonio Salvatore Rubino, Rosalia Latino, Fabio Giannone, Raffaele Lanteri, Beniamino Scilletta, Antonio Di Cataldo
International Surgery.2015; 100(4): 617. CrossRef Factors affecting sphincter-preserving resection treatment for patients with low rectal cancer
ZHENQIANG SUN, XIANBO YU, HAIJIANG WANG, MING MA, ZELIANG ZHAO, QISAN WANG
Experimental and Therapeutic Medicine.2015; 10(2): 484. CrossRef Tumour border configuration in colorectal cancer: proposal for an alternative scoring system based on the percentage of infiltrating margin
Eva Karamitopoulou, Inti Zlobec, Viktor Hendrik Koelzer, Rupert Langer, Heather Dawson, Alessandro Lugli
Histopathology.2015; 67(4): 464. CrossRef Tumor budding in the clinical management of colon and rectal cancer
Viktor H Koelzer, Inti Zlobec, Alessandro Lugli
Colorectal Cancer.2014; 3(4): 387. CrossRef Clinical Management of Localized Colon Cancer with Capecitabine
J. Quidde, D. Arnold, A. Stein
Clinical Medicine Insights: Oncology.2012; 6: CMO.S8194. CrossRef Early Detection of Colorectal Cancer, Is It a Guarantee for the Cure of Cancer?
Kang Young Lee
Journal of the Korean Society of Coloproctology.2012; 28(1): 6. CrossRef
|